Gil Leibowitz
Impact in
-
- Diabetes Management and Research
- Surgery top 2%
- Pancreatic function and diabetes
Papers in
- Surgery 36
- Pancreatic function and diabetes 35
-
- Metabolism, Diabetes, and Cancer 13
- PI3K/AKT/mTOR signaling in cancer 4
- Co-authors
- Erol Cerasi (28 shared papers)Ν. Kaiser (11 shared papers)Nurit Kaiser (11 shared papers)Yafa Ariav (7 shared papers)David J. Gross (11 shared papers)Mali Ketzinel‐Gilad (4 shared papers)Fred Levine (4 shared papers)Etty Bachar-Wikström (5 shared papers)
- Journals
- Diabetologia (8 papers)Diabetes (7 papers)Endocrinology (4 papers)Clinical Endocrinology (2 papers)Journal of the American Society of Nephrology (2 papers)
- Partner nations
- IsraelUnited StatesSweden
In The Last Decade
Gil Leibowitz
53 papers receiving 3.1k citations
Peers
Comparison fields: 5 of 104
- Endocrinology, Diabetes and Metabolism 809
- Surgery 1.4k
- Cell Biology 380
- Physiology 106
- Aging 39
Countries citing papers authored by Gil Leibowitz
This map shows the geographic impact of Gil Leibowitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gil Leibowitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gil Leibowitz more than expected).
Fields of papers citing papers by Gil Leibowitz
This network shows the impact of papers produced by Gil Leibowitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gil Leibowitz. The network helps show where Gil Leibowitz may publish in the future.
Co-authors
The 25 scholars most cited alongside Gil Leibowitz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 54 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 322 | |
| 2 | 2003 | 175 | |
| 3 | 2012 | 171 | |
| 4 | 1999 | 171 | |
| 5 | 2017 | 155 | |
| 6 | 1999 | 151 | |
| 7 | 1996 | 150 | |
| 8 | 1999 | 147 | |
| 9 | 1999 | 126 | |
| 10 | 2009 | 125 | |
| 11 | 2016 | 122 | |
| 12 | 1995 | 120 | |
| 13 | 2013 | 100 | |
| 14 | 2014 | 79 | |
| 15 | 2017 | 67 | |
| 16 | 2008 | 64 | |
| 17 | 2001 | 63 | |
| 18 | 2016 | 62 | |
| 19 | 2013 | 55 | |
| 20 | 2013 | 51 |
About Gil Leibowitz
Gil Leibowitz is a scholar working on Surgery, Molecular Biology, Endocrinology, Diabetes and Metabolism, Epidemiology and Genetics, having authored 54 papers that have together received 3.2k indexed citations. Recurring topics across this work include Pancreatic function and diabetes (35 papers), Metabolism, Diabetes, and Cancer (13 papers), Diabetes Management and Research (8 papers), Diabetes and associated disorders (8 papers), Autophagy in Disease and Therapy (7 papers), Cannabis and Cannabinoid Research (5 papers), Endoplasmic Reticulum Stress and Disease (4 papers) and PI3K/AKT/mTOR signaling in cancer (4 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (809 citations), Surgery (1.4k citations), Cell Biology (380 citations), Physiology (106 citations) and Aging (39 citations). Gil Leibowitz has collaborated with scholars based in Israel, United States and Sweden. Frequent co-authors include Erol Cerasi, Ν. Kaiser, Nurit Kaiser, Yafa Ariav, David J. Gross, Mali Ketzinel‐Gilad, Fred Levine, Etty Bachar-Wikström, Jakob D. Wikström and Matthew P. Frosch. Their work appears in journals such as Diabetologia, Diabetes, Endocrinology, Clinical Endocrinology and Journal of the American Society of Nephrology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.